Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

843.47
-8.5600-1.00%
Pre-market: 862.3718.90+2.24%04:00 EDT
Volume:496.25K
Turnover:418.78M
Market Cap:86.84B
PE:20.86
High:859.34
Open:858.19
Low:837.63
Close:852.03
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.69
T/O Rate:0.50%
Dividend:3.64
Dividend Rate:0.43%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.74
PE(LYR):20.33

Loading ...

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Reuters
·
11 hours ago

Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
12 hours ago

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Yesterday

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Yesterday

Movement Alert|Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, RBC Says Company Weighing Expanded Sanofi Partnership

Market Focus
·
Yesterday

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.01% in Regular Trading, RBC Says Company Weighing Expanded Sanofi Partnership

Market Focus
·
Sep 02

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.
·
Sep 01

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Reuters
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Aug 25

Regeneron Selects Veeva Vault CRM for Global Rollout

Reuters
·
Aug 25